New Covid jabs promote vaccination drive in Germany amid cases surge

Last updated on January 7th, 2022 at 09:23 am

Germany

The government of Germany will be approving new Covid jabs which will mostly make people come forward to receive their vaccination doses even more passionately. 

The European Medicines Agency (EMA) had recently approved a new protein-based Covid-19 vaccine which will supposedly play an important role in drawing people to get the much needed inoculation. These are specifically meant for people who are refusing to get the available doses of vaccines.

The EMA had earlier approved two doses of  Novavax vaccine on Monday post which the German advisory board will be expectedly following a procedure that will promote the usage of the vaccine soon. With this move, health experts will be at ease as it will impact the surging level of infections of the new Omicron variant. 

Related Posts

As per the latest developments, the first dose of Novavax is expected to be administered in Germany this New Year itself. It is a US based drug maker which has come up with a vaccine named Nuvaxovid but the procedure to approve it was delayed by a series of lengthy production issues. 

The new vaccine introduction has come after a year of introducing Pfizer/BioNTech and Moderna in the market which were made by Oxford/AstraZeneca and Johnson & Johnson. The new science allows Nuvaxovid to use a traditional form of tackling the virus attack. 

The other four available vaccines simulate a virus in the body but the new vaccine has an efficacy rate of 90 percent in preventing infection with the Alpha variant. The trials are further being conducted if it is completely safe for usage or not and its ability to fight simulate a virus in the body. 

EU Reporter

As vast is the European region, the more diverse are the developments and news that are to be known. I bring to table the news and political affairs from region to your screens.

Recent Posts

The Rise of Deepfake Technology and How to Spot It

Deepfake technology has swiftly developed from a small-time AI experiment to a mass-scale online menace that affects politics, media, cybersecurity,… Read More

January 3, 2026

Trump Breaks Silence on Venezuela Operation in First Post-Action Interview

Former U.S. President has granted his first interview with The New York Times in the light of a recent U.S.… Read More

January 3, 2026

Iran Protests Enter Sixth Day as Economic Crisis and Political Repression Spark Nationwide Unrest

It is the sixth day of the Iranian protests that have demonstrated a growing crisis in the country as a… Read More

January 3, 2026

10 Must-See TV shows to Watch in 2026: What to Watch Next Year

The 2026 television lineup is already becoming one of the most anticipated lineups in recent history, with long-awaited returns, radical… Read More

January 3, 2026

Renewed Tensions Reported in Southern Yemen Near Saudi Border

The situation in Yemen deteriorated overnight as combat erupted on the border between the country and Saudi Arabia between Saudi-supported… Read More

January 3, 2026

Most Anticipated Movies of 2026: Hollywood’s Biggest Blockbusters and Cinematic Events

It is expected that 2026 is going to be one of the most ambitious and high-stakes years in the history… Read More

January 2, 2026

This website uses cookies.

Read More